Adenovirus is one of the well-studied double-stranded DNA viruses. However, the mechanisms of its DNA packaging and virion assembly are still not fully understood. One of the unique features of adenovirus is that the unpackaged viral DNA is associated with core protein pVII. Packaging of viral DNA bound with proteins has not been reported from other viruses. To characterize how viral DNA bound with protein pVII is packaged, we performed experiments to see if protein pVII interacts with the known DNA packaging proteins or the packaging sequence. Our results demonstrated that protein pVII interacted with the viral IVa2 and L1 52/55 kDa proteins, which are the known viral DNA packaging proteins. Furthermore, our protein-DNA binding experiments demonstrated that the IVa2 protein mediates the specific interaction with the packaging sequence, whereas protein pVII and the L1 52/55 kDa protein bind to DNA non-specifically. Although the non-specific binding of protein pVII and the L1 52/55 kDa protein do not appear to affect the specific binding of the IVa2 protein to the packaging sequence, and the specific binding of the IVa2 protein does not appear to block the bindings of protein pVII and the L1 52/55 kDa protein to the packaging sequence, the possibility of a cooperative binding among the IVa2 protein, the L1 52/55 kDa protein and protein pVII on the packaging sequence needs to be further determined. In summary, the results indicate that the assembly of the DNA packaging initiation complex may be mediated by the specific interaction of the IVa2 protein with the packaging sequence and other viral proteins, such as protein pVII and the L1 52/55 kDa protein. D
Introduction
Human adenoviruses cause acute respiratory infections in young children and military recruits (Brandt et al., 1969; Mallet et al., 1966) . They also cause infections in the eye (Foy et al., 1968) , gastrointestinal tract (Wood, 1988) , and urinary bladder (Numazaki et al., 1973) . Most of the adenovirus infections are self-limited in immunocompetent hosts. However, infections in immunocompromised patients, such as organ and bone marrow transplant (BMT) patients and patients with AIDS (Bruno et al., 2004; Kojaoghlanian et al., 2003) , can be disseminated and lethal. In the past few decades, adenovirus has been used as a model system to study viral DNA replication, gene expression, and virus-host interactions and as a potent vector system for vaccines, for example, potential HIV vaccines (Shiver and Emini, 2004) , and for gene therapy. Although the biology of adenovirus has been extensively studied, the mechanisms of viral DNA packaging and virion assembly are still not fully understood.
The adenovirus virion is an icosahedron which contains a double-stranded DNA genome of about 36 kbp. The viral genome is protected by a capsid shell composed of three major proteins: hexon, penton base, and fiber. It has been believed that these structure proteins form an empty capsid, then viral DNA and its associated core proteins are inserted into the preformed empty capsids. One of the unique features of adenovirus is that the viral DNA is organized 0042-6822/$ -see front matter D 2005 Elsevier Inc. All rights reserved. doi:10.1016/j.virol.2005.01.048 into chromatin-like structure by the core proteins in the virion. The viral core proteins include terminal protein (TP), proteins VII and V, and peptide mu. The terminal protein is involved in viral DNA replication and is not required for viral DNA packaging (Ostapchuk and Hearing, 2003) . Protein VII is the major core protein, and~1170 to 1350 copies are present in the virion (Prage and Pettersson, 1971) . It has been shown that protein VII has functional features in common with cellular histones, which condense the viral DNA (Chatterjee et al., 1986a (Chatterjee et al., , 1986b Fedor and Daniell, 1980; Lischwe and Sung, 1977; Sung et al., 1977; Vayda et al., 1983) . Like protein VII, protein V and peptide mu are also arginine-rich proteins that are associated with viral DNA in the core (Anderson et al., 1989; Frearson and Crawford, 1972; Prage et al., 1968; Russell et al., 1971; Tagawa et al., 2002; Weber and Anderson, 1988) . These core proteins have been shown to interact with each other and organize the viral DNA into nucleosome-like structure in mature virion (Corden et al., 1976; Mirza and Weber, 1982; Vayda et al., 1983) . Protein pVII, the precursor of protein VII, has 23 additional amino acids on the N-terminal of the protein VII (Lunt et al., 1988) . Protein pVII is packaged into the capsid and cleaved in the virion by a virus-encoded proteinase into its mature form, VII, to accomplish the final step of virion maturation. During the viral infection, the protein VII-DNA complex travels to the nucleus and may serve as a template for early viral gene transcription (Haruki et al., 2003; Spector et al., 2003) . Interestingly, protein pVII associates with unpackaged viral DNA during late phases of viral infection (Brown and Weber, 1980; Chatterjee et al., 1986a Chatterjee et al., , 1986b Dery et al., 1985; Weber and Philipson, 1984) . The unpackaged viral DNA is organized in a manner similar to viral chromatin in mature virions (Brown and Weber, 1980; Daniell et al., 1981; Tate and Philipson, 1979; Weber and Philipson, 1984) . How such a protein pVII-DNA complex is packaged into viral capsid is not clear. This situation does not fit the established models for DNA packaging from other viruses, such as bacterial phages (Catalano, 2000; Earnshaw and Casjens, 1980; Fujisawa and Morita, 1997; Guo et al., 1998; Huang et al., 2004; Serwer, 2003; Smith et al., 2001) . Key questions involve whether protein pVII are packaged together with DNA or separately. If protein pVII are packaged with the viral DNA, what roles does protein pVII play in this process, and how does the viral DNA packaging motor complex move along DNA bound with protein pVII? If protein pVII is packaged separately, how does the packaging motor complex remove protein pVII on the viral DNA before the viral DNA is packaged? Both possibilities may require the interaction between protein pVII and the DNA packaging machinery.
The viral DNA packaging machinery includes the packaging sequence and the proteins that recognize the packaging sequence, which form a DNA packaging initiation and motor complex. The packaging sequence is located at the left end of the viral genome (nucleotides 194 to 358 in adenovirus type 5 [Ad5]) (Hammarskjold and Winberg, 1980; Hearing and Shenk, 1983) . This region in Ad5 contains several functionally redundant sequence elements called A repeats. Most of the A repeats have a consensus motif that is important for DNA packaging Hearing, 1990, 1992; Hearing, 1997, 1998) . To package the viral DNA, there should be proteins that recognize the packaging sequence. Several viral proteins have been shown to be involved in DNA packaging. One of these proteins is the L1 52/55 kDa protein. A mutant virus, which does not express this protein, makes only the empty capsids containing no viral DNA (Gustin and Imperiale, 1998) . Another protein is called IIIa protein. Temperaturesensitive mutations in this protein cause accumulation of intermediate particles containing only the left end of the viral genome at the non-permissive temperature (D'Halluin et al., 1978; Hasson et al., 1989) . A third protein, the IVa2 protein, has been demonstrated to play an important role in viral DNA packaging. First, the IVa2 protein interacts with the L1 52/55 kDa protein (Gustin et al., 1996) . Second, the IVa2 protein is the viral protein that is known to bind to the packaging sequence (Zhang and Imperiale, 2000) . A serotype-specific interaction of the IVa2 protein with the packaging sequence has been demonstrated to be essential for viral DNA packaging (Zhang et al., 2001) . In addition, a IVa2-mutant virus does not assemble its capsid properly (Zhang and Imperiale, 2003) . These results indicate that the IVa2 protein together with other proteins, such as the L1 52/ 55 kDa and IIIa proteins may form an initiation and motor complex around the packaging sequence to mediate viral DNA packaging. The function of such a motor complex is to provide energy to packaging viral DNA bound with protein pVII. This may require a specific interaction of the motor complex with the protein pVII. It has been suggested that the IVa2 protein is present in the cores purified from the disrupted virions (Goding and Russell, 1983; Weber et al., 1983) . The presence of the IVa2 protein in the purified cores indicates that protein pVII may cooperate with the IVa2 protein and thereby play a role in viral DNA encapsidation. In this study, we investigated the interaction of the protein pVII with the viral DNA packaging machinery.
Results

Interaction of pVII with the IVa2 protein
Since the viral DNA is associated with protein pVII before it is packaged, to package such a protein-DNA complex into viral capsid, it may require a specific interaction between the viral packaging proteins and protein pVII. Two of the known proteins, the IVa2 and L1 52/55 kDa proteins, are involved in viral DNA packaging (Gustin and Imperiale, 1998; Imperiale, 2000, 2003; Zhang et al., 2001) . Therefore, we started to investigate whether protein pVII and its mature form, VII, interact with these two proteins. To determine the interactions between the proteins VII and pVII with the IVa2 protein, we cloned the pVII and VII genes into a GFP fusion vector, pEGFP-C1. The pVII and VII genes were fused to the C terminal of the GFP. The expression of GFP-pVII and GFP-VII fusion proteins in transfected 293 cells was demonstrated by fluorescence microscopy and by immunoblotting with an anti-GFP antibody (Fig. 1) . It has been shown that both pVII and VII have nucleus and nucleolus colocalization signals (Lee et al., 2003) . In agreement with these previous findings, we found that both GFP-pVII and GFP-VII localized to the nucleus (Fig. 1) , indicating that proteins pVII and VII were correctly fused to the GFP. This is confirmed by the anti-GFP antibody in an immunoblotting assay ( Fig. 1) . Although the intensity of the green fluorescence of both GFP-pVII and GFP-VII fusion proteins was similar ( Fig. 1 , the middle two panels); however, in the whole cell lysate, the amounts of GFP-pVII were less than that of GFP-VII ( Fig. 1 , the left penal). Therefore, we performed experiments to detect GFP-pVII and GFP-VII in the cell pellet after lysing the cells with our lysis buffer. We found that the amounts of GFP-pVII in the cell pellet were more than that of GFP-VII, indicating that GFP-pVII was associated more with cell pellet, perhaps cellular DNA, than GFP-VII was.
Then, we cotransfected 293 cells with a IVa2 expression vector, pBK-Trip-IVa2 (Zhang et al., 2001) , and pEGFP-VII or pEGFP-pVII or pEGFP-C1 (GFP alone). Immunoprecipitation (IP) assays were performed using the anti-GFP antibody and lysates from the cotransfected cells. The precipitated proteins were detected by immunoblotting with an anti-IVa2 antibody (Zhang and Imperiale, 2003) . Fig. 2A shows that the IVa2 protein was immunoprecipitated in the presence of GFP-VII and GFP-pVII but not in the presence of GFP alone using anti-GFP antibody. The results indicated that both protein VII and pVII interact with the IVa2 protein.
These interactions were further confirmed in virusinfected cells. We transfected 293 cells with pEGFP-VII or pEGFP-pVII or pEGFP-C1. Six hours after transfection, the cells were infected with wild type Ad5 at multiplicity of infection (MOI) of 5/cell. Twenty four hours after infection, the cells were harvested to make cell lysates. Immunoprecipitation assays were performed using the anti-GFP antibody, and the IVa2 protein was detected by immunoblotting. Similar to the results from the cotransfection assays, the GFP-VII and GFP-pVII could coprecipitate the IVa2 protein in infected cells whereas GFP alone did not (Fig.  2B ). These results indicated that both proteins pVII and VII interact with the IVa2 protein. Since pVII has 23 additional amino acids on the N-terminal of the protein (Lunt et al., 1988) as compared with VII, and both pVII and VII interact with the IVa2 protein, the first 23 amino acids may not be part of the IVa2-binding domain, however, it is still possible that these first 23 amino acids could be involved in modulate the binding activity.
Interaction of pVII with the L1 52/55 kDa protein Similar assays were performed to determine whether protein VII or pVII interacts with the L1 52/55 kDa protein.
In this assay, we used pEGFP-IVa2, a GFP-IVa2 fusion protein expression vector, as a positive control since the IVa2 protein interacts with the L1 52/55 kDa protein (Gustin et al., 1996) . The expression of the GFP-IVa2 fusion protein was confirmed by both anti-GFP and anti-IVa2 antibodies in immunoblotting assays (data not shown). The L1 52/55 kDa protein was detected by immunoblotting with an anti-L1 antibody. The results ( Fig. 3 ) indicated that both proteins VII and pVII interact with the L1 52/55 kDa protein in infected cells. Since both pVII or VII and the L1 52/55 kDa protein interact with the IVa2 protein, it is possible that the interaction detected between pVII or VII with the L1 52/55 kDa protein in infected cells is through the IVa2 protein.
Specific interaction of the IVa2 protein with the packaging sequence
Since both the IVa2 and L1 proteins are involved in viral DNA packaging (Gustin and Imperiale, 1998; Imperiale, 2000, 2003; Zhang et al., 2001) , the interaction of protein pVII with the IVa2 and L1 52/55 kDa proteins suggest that protein pVII may play a role in viral DNA packaging. Since the IVa2 protein binds to the packaging sequence, and protein pVII binds to DNA nonspecifically (Russell and Precious, 1982) , we investigated whether the nonspecific binding of protein pVII interfere with the formation of the IVa2-complex on the packaging sequence. To test these, we performed DNA binding protein pull-down assays using AI-II repeat of the packaging sequence as a bait. The biotin-labeled AI-II repeats of the packaging sequence, a mutant AI-II repeats that blocked the IVa2specific binding (Zhang and Imperiale, 2000) and a nonspecific DNA sequence (Table 1) were immobilized on Streptavidin Magnetic Beads. DNA binding proteins in cell nuclear extract (NE) were pull-down and detected by immunoblotting. First, we determined the specificity of the IVa2 protein on the packaging sequence using this binding system. As shown in Fig. 4 , significant more IVa2 protein was detected to bind to the wild type AI-II packaging sequence than to the mutant packaging sequence. This was true when using the NE from both infected cells and pBK-trip-IVa2 + pEGFP-pVII cotransfected cells. Furthermore, we observed low levels of nonspecific binding of the IVa2 protein to the mutant AI-II sequence. To determine whether the mutations in AI-II sequence totally block the specific binding of the IVa2 protein, we did experiments using a nonspecific sequence (Table 1) as a negative control. Similar low levels of nonspecific binding of the IVa2 protein still existed (data not shown). These results indicated that the IVa2 protein interact with the packaging sequence specifically in the binding system, which is inconsistent with our previous finding (Zhang and Imperiale, 2000) . Furthermore, the presence of GFP-pVII did not appear to affect the specific binding of the IVa2 protein to the packaging sequence.
Interaction of the protein pVII with the packaging sequence
As demonstrated above, the presence of GFP-pVII did not affect the specific binding of the IVa2 protein to the packaging sequence. Next, we determined whether protein pVII bound to the packaging sequence with or without the expression of the IVa2 protein. The same reactions used above (Fig. 4) were immunoblotted to detect GFP-pVII after the pull-down assay using an anti-GFP antibody. Fig.  5 shows the binding of GFP-pVII to the packaging sequence. We observed nonspecific binding of GFP-pVII to DNA with and without the presence of the IVa2 protein.
Similar results were obtained when we used the nonspecific sequence as a control (data not shown). In the reactions when both protein GFP-pVII and the IVa2 protein were present (Fig. 5, Lane 5) , we expected that the specific binding of the IVa2 protein to the wild type AI-II sequence would block the nonspecific binding of GFP-pVII. Interestingly, the specific binding of the IVa2 protein did not block the binding of GFP-pVII to the packaging sequence. The interaction between the IVa2 protein and protein pVII provided an explanation for this observation. Protein pVII might remain in the IVa2- Fig. 3 . Proteins pVII and VII interact with the L1 52/55 kDa protein. Immunoprecipitation assays were performed using an anti-GFP antibody and cell lysates from 293 cells transfected with different GFP fusion vectors and then infected with Ad5 at a MOI of 5 pfu/cell. The precipitated L1 52/ 55 kDa protein was detected by immunoblotting using an anti-L1 antibody. Table 1  DNA sequences for protein binding assays   AI-II  TAG TAAA TTTGGGCGTAAC CGAG TAAGA TTTGGCCA T TT TCG  AI-II-mu  TAG TAAA TT a c GGCGTAAC t a A t TAAGA TT a c GCCA T TT TCG  Non-specific  GGGAA T TGTAG TAT TCT TAAGA TGGGAAGTG ACGTAATGTGG The IVa2 binding motifs and their mutations are underlined. Fig. 4 . Specific binding of the IVa2 protein to the packaging sequence. DNA binding assays were performed using packaging sequence AI-II repeat (wt) or its mutant form, AI-II-mu (mu), conjugated to magnetic beads and nuclear extract (NE) from differently treated 293 cells. The IVa2 protein was detected by immunoblotting using an anti-IVa2 antibody.
packaging sequence complex through the interaction with the IVa2 protein. However, it is still possible that protein pVII and the IVa2 protein bind to the packaging sequence on separate probes or different binding sites.
Interaction of the L1 52/55 kDa protein with the packaging sequence
Since the L1 52/55 kDa protein is required for viral DNA encapsidation (Gustin and Imperiale, 1998) , and it interacts with the IVa2 protein and protein pVII, we investigated whether the L1 52/55 kDa protein is a component of the protein complex formed with the packaging sequence. Similar binding assays as above were performed using nuclear extracts from viral infected cells. The L1 protein was detected with an anti-L1 antibody. We found that the L1 52/55 kDa protein bound to DNA nonspecifically. Equal amount of L1 52/55 kDa protein was pulled down by both wild type AI-II repeat and the mutant AI-II (Fig. 6) . In a separate experiment, we tested whether the L1 52/55 kDa protein bound to a nonspecific DNA sequence (Table 1) . We found that the L1 52/55 kDa protein could bind to the nonspecific DNA as well (data not shown). These results indicated that the L1 protein could interact with DNA nonspecifically. Since the IVa2 protein bound to wild type AI-II specifically, similar to the binding property of protein pVII, the specific binding of the IVa2 protein did not appear to block the binding of the L1 52/55 kDa protein to the wild type AI-II. Furthermore, the binding of L1 52/55 kDa protein to wild type AI-II did not appear to affect the specific binding of the IVa2 protein detected in the assay above (Fig. 4) . In the presence of the IVa2 protein, it is possible that the binding of the 52/55 kDa protein to the packaging sequence is mediated by the interaction with the IVa2 protein. However, another possibility is that these two proteins may bind to the packaging sequence on separate probes or different binding sites.
Since we found that the L1 52/55 kDa protein and protein pVII interacted with DNA nonspecifically, we next determined whether other viral or cellular proteins bound to DNA nonspecifically in our binding assay conditions. We examined the viral E1A protein and the h-actin cellular protein. Fig. 7 showed that both E1A protein and h-actin were detected in Ad5-infected and uninfected 293 cells, however, they were not detected in the DNA binding pulldown products. These result indicated that our in vitro binding conditions did not favor binding of all the proteins to DNA, and that the interaction of the L1 52/55 kDa protein with DNA might not be an artifact of the assay.
Discussion
An established model for viral DNA packaging comes from studies of many bacteriophages, in which viral DNA is packaged into preformed capsid shells (Catalano, 2000; Earnshaw and Casjens, 1980; Fujisawa and Morita, 1997; Guo et al., 1998; Huang et al., 2004; Serwer, 2003; Smith et al., 2001) ). Among mammalian viruses, herpesviruses, including herpes simplex virus (HSV) and cytomegalovirus (CMV) have been described to use a similar pathway as phage E to package its DNA (Newcomb et al., 1994 (Newcomb et al., , 1996 Newcomb et al., 2001; Savva et al., 2004; Stow, 2001; White et al., 2003) . Several lines of evidence suggest that adenovirus may use a similar pathway to package its DNA. Empty capsids are produced in parallel to mature virions in infected cells (Sundquist et al., 1973) . Intermediate particles with buoyant densities between empty capsids and mature virions have been isolated from infected cells. These intermediates contain small DNA fragments that are mainly Fig. 5 . Interaction of protein pVII with the packaging sequence. DNA binding assays were performed as described in Fig. 4 . GFP-pVII fusion protein was detected by immunoblotting using an anti-GFP antibody. Fig. 6 . Interaction of the L1 52/55 kDa protein with the packaging sequence. DNA binding assays were performed as described in Fig. 4 . GFP-pVII fusion protein was detected by immunoblotting using an anti-L1 antibody. Fig. 7 . Specificity of the DNA binding assays. DNA binding assays were performed as described in Fig. 4 . After binding, E1A proteins and h-actin were detected by immunoblotting using anti-E1A and anti-h-actin antibodies (Lanes 1 and 2). Lanes 3 and 4 detected the E1A protein and h-actin in the NE of 293 cells or Ad5-infected 293 cells. from the left end of the genome (D'Halluin et al., 1978) . Kinetic radiolabeling and pulse-chase studies suggest that empty capsids and intermediate particles are precursors of mature virions (Horwitz et al., 1969; Ishibashi and Maizel, 1974; Sundquist et al., 1973) . A unique feature of adenoviruses is that there are histone-like protein pVII bound to viral DNA before the viral DNA is packaged (Brown and Weber, 1980; Chatterjee et al., 1986a Chatterjee et al., , 1986b Dery et al., 1985; Weber and Philipson, 1984) . Packaging of virus DNA bound with proteins has not been reported from studies of other viruses. We proposed that to package such a protein-DNA complex, interactions between protein pVII and DNA packaging proteins should occur. Our results that protein pVII interacts with the IVa2 and L1 proteins supports this assumption.
Previously, we have shown that the IVa2 protein interacts with the packaging sequence and is involved in viral DNA packaging and virion assembly Imperiale, 2000, 2003; Zhang et al., 2001) . The IVa2 protein is a component of two DNA-protein complexes formed with the packaging sequence. These experiments were performed using electrophoresis mobility shift assays. In this study, we confirmed these previous studies with a different in vitro binding system. We have found that the IVa2 protein is a component that determines the specificity of the interaction of the packaging sequence-protein complex. Consistent with the previous finding (Russell and Precious, 1982) , protein pVII binds to DNA nonspecifically. However, the nonspecific binding of protein pVII does not interrupt with the specific binding of the IVa2 protein with the packaging sequence. Furthermore, with the specific binding of the IVa2 protein, protein pVII is still present in the complex with the packaging sequence. Similar situation may be true for the L1 52/55 kDa protein. These results indicate that the assembly of the DNA packaging initiation complex may be mediated by the specific interaction of the IVa2 protein with the packaging sequence and other viral proteins, such as protein pVII and the L1 52/55 kDa protein. The results of this study provided the molecular bases to understand how DNA-pVII complex is packaged into capsid.
Based on our results, there may be three possible ways for a DNA-protein complex to be packaged into capsid. The first possibility is that viral DNA is transferred into the capsid with the bound protein pVII (Fig. 8A) . Therefore, the DNA packaging initiation and motor complex will have to transfer viral DNA covered with protein pVII. This would be a novel mechanism of DNA packaging, which has not been previously described. If this is the case, then interaction of protein pVII with the DNA packaging protein is likely involved, which is supported by our data that protein pVII interacts with the IVa2 protein. The second possibility is that the DNA packaging machinery only transfers naked DNA without protein pVII (Fig. 8B) . Protein pVII may penetrate the capsid freely so that it can be associated with the packaged DNA again to form the chromatin-like structure in the capsid. If this is true, then an interesting question is how the DNA packaging motor strips protein pVII off to make the DNA ready for packaging. Very recently, it has been shown that a protein in yeast, called Rad54, can mediate chromatin remodeling and remove the nucleosome proteins off the cellular DNA (Alexeev et al., 2003) . It is possible that a similar mechanism is used by the viral DNA packaging machinery to remove protein pVII from the viral DNA in this case. The third possibility is that protein pVII and DNA form a chromatin-like structure first, and then the viral capsid proteins assemble around it (Fig. 8C ). There is no direct evidence to support this possibility; however, there are other viruses may use this model to package their viral genome. Poliovirus is one of the viruses that may assemble its structural proteins around the genome, which is RNA in this case (Putnak and Phillips, 1981; Rombaut et al., 1990; Verlinden et al., 2000) . Among the DNA viruses, simian virus 40 is thought to assemble its capsid around its circular DNA genome. Recently, it has been shown that a cellular factor, Sp1, recruits two of the capsid proteins, VP2 and VP3, to the viral packaging signal to form a packaging center around which VP1, the major capsid protein, assembles (Gordon-Shaag et al., 2002) . Whether this is true for adenovirus DNA packaging requires more direct evidence. 
Materials and methods
Cell culture
All cell lines were maintained in Dulbecco's modified Eagle medium (DMEM) with 10% fetal bovine serum (FBS), at 37 8C in a 5% CO 2 incubator. Infection of 293 cells, a human embryonic kidney cell line that express adenovirus type 5 (Ad5) E1A and E1B proteins, was carried out as described previously (Zhang and Imperiale, 2003) .
Plasmids
The pVII and VII genes were amplified by PCR using the following two different forward primers, GCGCGG-ATCCGCAAGCATGTCCATCCTTATA and GCGCGGA-TCCGCC ACCATGGGCGGGGCCAAGAAGCGCT, and a shared reverse primer, GCGCCTCGAGAA CAGTACG-AGTCTAAGTAGT. First, pVII and VII genes were cloned into the pBK-CMV vector at the BamHI and XhoI sites to generate pBK-pVII and pBK-VII. Then, pBK-pVII and pBK-VII were digested with BamHI and KpnI to release the pVII and VII fragments. pEGFP-pVII and pEGFP-VII were generated by cloning the BamHI-plus-KpnI digested pVII and VII fragments from pBK-pVII and pBK-VII into the BglII and KpnI sites of pEGFP-C1. Similarly, to generate pEGFP-IVa2, the IVa2 DNA fragment was released from pBK-Trip-IVa2 (Zhang and Imperiale, 2003) with BamHI and KpnI and cloned into the BglII and KpnI sites of pEGFP-C1.
Transfections 293 cells were transfected with pEGFP-(C1, pVII, VII, IVa2) either alone, or cotransfected with pBK-trip-IVa2. Transfections were performed by the calcium phosphate method. 293 cells were plated 1 day prior to transfection and the medium from the cells was changed 3 h before transfection. Sterile, deionized water and the DNA (10 Ag) were prepared in a sterile conical to a total volume of 250 Al together. Then, 300 Al of 2Â HBS (50 mM HEPES, 280 mM NaCl, 1.5 mM Na 2 HPO 4 , pH: 7.05), and 50 Al of 2 M CaCl 2 were added to the solution. After the addition of the CaCl 2, the solution was mixed slowly with a sterile pipette. Then, the solution was incubated for 30 min at room temperature. The total solution was added to subconfluent cells in 60-mm-diameter dishes drop by drop while slowly rocking. The cells were incubated for 16 h at 37 8C in a CO 2 incubator.
Immunoprecipitation
Cell lysates were made from the cotransfected or transfected + infected cells as described (Harris et al., 1996) . Cell lysates were incubated with 5 Al of anti-GFP antibody (Roche Diagnostic Corporation) for 1 h on ice.
Then, the samples were incubated with 25 Al of protein-G-Agarose beads for 3-12 h at 4 8C with rocking. Immunolcomplexes bound to the beads were washed three times with lysis buffer for 10 min while rotating at 4 8C. All traces of lysis buffer were removed by a quick centrifugation and removal of the supernatants. Immunol-complexes bound to beads were released into gel-loading buffer (2% sodium dodecyl sulfate [SDS] , 60 mM Tris [pH 6.8], 10% glycerol, 0.1% bromophenol blue, 292 mM h-mercaptoethanol) by boiling for 3-5 min at 95 8C. Samples were resolved by SDS-PAGE with 10% polyacrylamide and the gels were subjected to immunoblotting.
Immunoblotting
Following SDS-PAGE, proteins were transferred to nitrocellulose membrane in 25 mM Tris-200 mM glycine-20% methanol for 90 min at 65 V and 4 8C. After transfer, the membrane was placed in blocking solution of 5% nonfat dried milk in PBS-T (PBS plus 0.1% Tween 20) for 1 h at room temperature with rocking. Then, the membrane was incubated in blocking solution containing the primary antibody for 90 min at room temperature with rocking. Afterwards, the membrane was washed three times in PBS-T for 10 min each with rocking, and incubated in blocking solution with the secondary antibody (horseradish peroxidase linked) for 1 h at room temperature with rocking. The membrane was then washed three times in PBS-T as stated above, and then developed with enhanced chemiluminescence reagents (Amersham). For reprobing, the membranes were stripped in stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl [pH 6.7]) at 50 8C for 30 min while rotating and then reprobed as described above.
DNA-binding protein pull-down assay
Packaging sequence-binding proteins were detected using AI-II repeat as a bait immobilized on magnetic streptavidin beads (Roche Diagnostic Corporation). First, the 25 Al of the magnetic streptavidin beads were washed three times with 50 Al TEN 100 Binding Buffer (10 mM Tris-HCl, 1 mM EDTA, 100 mM NaCl, pH 7.5). Then, 0.5 Ag of biotin-labeled AI-II, mutant AI-II or a nonspecific double-stranded DNA sequence (Table 1) was added to the beads in 50 Al TEN 100 Binding Buffer and incubated for 15 min at room temperature to conjugate the biotinylated DNA to the magnetic streptavidin beads. The mixture was then washed two times with 200 Al TEN 1000 Binding Buffer (10 mM Tris-HCl, 1 mM EDTA, 1 M NaCl, pH 7.5), and washed two times with 200 Al Reaction Buffer (10 mM HEPES [pH 7.9], 20 mM KCl, 3 mM MgCl 2 , 100 mM EDTA, 12% Glycerol, 1 mM DTT). Next, the protein binding reaction was prepared by mixing 65 Al Reaction Buffer, 6.25 Al polyD (IC) [0.5 Ag/ Al], 3.13 Al poly-l-lysine [0.1%], 10 Al nuclear extract; and the reaction was incubated for 30 min at room temperature with 50 Al of the washed beads. Cell nuclear extracts were prepared as described previously (Zhang and Imperiale, 2000) . After incubation, the reaction was washed with 200 Al Reaction Buffer three times. The proteins were resolved by SDS-PAGE and analyzed by Western Blot.
